China Medicine Announces Conference Call to Discuss First Quarter 2008 Results
Joining Mr. Shensan Yang, Chairman and Chief Executive Officer of ChinaMedicine, will be, Ms. Huizhen Yu, Chief Financial Officer. The Company plansto make an earnings announcement prior to the call.
To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time: 800-688-0796. International callers should dial 617-614-4070, Conference Passcode:91479292.
If you are unable to participate in the call at this time, a replay willbe available for seven days starting on May 12, at 11:00 a.m. Eastern Time.To access the replay, dial 888-286-8010, international callers dial 617-801-6888, and enter the passcode of 57612969.
About China Medicine Corporation
China Medicine Corporation is a leading pharmaceutical company whichdiscovers, develops, and distributes over 2,200 pharmaceutical products inChina including prescription and over the counter (''OTC'') drugs, traditionalChinese medicine (''TCM'') products, herbs and dietary supplements. TheCompany distributes the products to wholesale distributors in 28 provinces,over 300 hospitals, 500 medicine companies, and 1,788 drug stores throughoutChina. The Company actively develops a number of proprietary products formany uses including oncology, high blood pressure and the removal of toxinsfrom food and animal feeds. For more information visit the Company's websiteat http://www.chinamedicinecorp.com .
This press release contains forward-looking statements concerning theCompany's business, products and financial results. The Company's actualresults may differ materially from those anticipated in the forward-lookingstatements depending on a number of risk factors including, but not limited to,the following: general economic and business conditions, development, shipment,market acceptance, additional competition from existing and new competitors,changes in technology, and various other factors beyond the Company's control.All forward-looking statements are expressly qualified in their entirety bythis Cautionary Statement and the risk factors detailed in the Company'sreports filed with the Securities and Exchange Commission. China MedicineCorporation undertakes no duty to revise or update any forward-lookingstatements to reflect events or circumstances after the date of this release.For more information, please contact: Company Contact: Ms. Huizhen Yu Chief Financial Officer China Medicine Corporation Tel: +86-20-8739-1718 Email: firstname.lastname@example.org Investor Relations Contact: Mr. Crocker Coulson President CCG Elite Investor Relations Tel: +1-646-213-1915 (NY Office) Email: email@example.com Web: http://www.ccgelite.com
SOURCE China Medicine Corporation
You May Also Like